Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
243.2 GBX | +0.83% | +5.35% | +28.12% |
Dec. 04 | Petrofac jumps despite free cash flow miss | AN |
Dec. 04 | Capita to sell Fera Sciences stake to Bridgepoint for GBP60 million | AN |
Valuation
Fiscal Period : December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 4 059 | 1 569 | 1 916 | - | - |
Enterprise Value (EV) 1 | 3 820 | 1 569 | 1 812 | 2 246 | 2 300 |
P/E ratio | 70,2x | 13,0x | 18,9x | 13,6x | 12,6x |
Yield | 0,74% | 2,10% | 3,63% | 3,94% | 4,35% |
Capitalization / Revenue | 15,0x | 5,10x | 6,15x | 4,10x | 3,92x |
EV / Revenue | 14,1x | 5,10x | 5,82x | 4,81x | 4,70x |
EV / EBITDA | 33,5x | 11,2x | 13,5x | 9,79x | 9,63x |
EV / FCF | - | 139x | 19,7x | 14,4x | 14,8x |
FCF Yield | - | 0,72% | 5,07% | 6,93% | 6,75% |
Price to Book | 5,67x | 2,03x | 2,51x | 2,24x | 2,07x |
Nbr of stocks (in thousands) | 823 269 | 823 269 | 794 412 | - | - |
Reference price 2 | 4,93 | 1,91 | 2,41 | 2,41 | 2,41 |
Announcement Date | 3/24/22 | 3/16/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
Fiscal Period : December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 271 | 307 | 311 | 467 | 489 |
EBITDA 1 | 114 | 140 | 134 | 229 | 239 |
EBIT 1 | 102 | 125 | 119 | 225 | 231 |
Operating Margin | 37,7% | 40,7% | 38,1% | 48,0% | 47,2% |
Earnings before Tax (EBT) 1 | 62,6 | 127 | 111 | 201 | 221 |
Net income 1 | 57,8 | 121 | 101 | 168 | 173 |
Net margin | 21,4% | 39,2% | 32,5% | 36,0% | 35,4% |
EPS 2 | 0,07 | 0,15 | 0,13 | 0,18 | 0,19 |
Free Cash Flow 1 | - | 11,3 | 91,9 | 156 | 155 |
FCF margin | - | 3,68% | 29,5% | 33,3% | 31,7% |
FCF Conversion (EBITDA) | - | 8,05% | 68,7% | 67,9% | 65,0% |
FCF Conversion (Net income) | - | 9,37% | 90,9% | 92,6% | 89,6% |
Dividend per Share 2 | 0,04 | 0,04 | 0,09 | 0,10 | 0,10 |
Announcement Date | 3/24/22 | 3/16/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period : December | 2022 S2 | 2023 S1 |
---|---|---|
Net sales 1 | 167 | 138 |
EBITDA 1 | 78,5 | 55,6 |
EBIT 1 | 70,8 | 52,4 |
Operating Margin | 42,3% | 38,0% |
Earnings before Tax (EBT) 1 | 79,1 | 53,1 |
Net income 1 | 75,7 | 48,2 |
Net margin | 45,2% | 35,0% |
EPS | - | - |
Dividend per Share | - | - |
Announcement Date | 3/16/23 | 7/25/23 |
1GBP in Million
Estimates
Balance Sheet Analysis
Fiscal Period : December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | 330 | 384 |
Net Cash position 1 | 238 | - | 105 | - | - |
Leverage (Debt/EBITDA) | - | - | - | 1,44x | 1,61x |
Free Cash Flow 1 | - | 11,3 | 91,9 | 156 | 155 |
ROE (net income / shareholders' equity) | 11,3% | 15,2% | 14,5% | 17,9% | 16,0% |
Shareholders' equity 1 | 513 | 793 | 697 | 938 | 1 081 |
ROA (Net income/ Total Assets) | 4,97% | - | 5,38% | 7,26% | 5,61% |
Assets 1 | 1 163 | - | 1 879 | 2 315 | 3 087 |
Book Value Per Share 2 | 0,87 | 0,94 | 0,96 | 1,08 | 1,17 |
Cash Flow per Share 2 | 0,06 | 0,04 | 0,09 | 0,20 | 0,21 |
Capex 1 | 6,30 | 22,6 | 4,00 | 11,5 | 11,5 |
Capex / Sales | 2,33% | 7,35% | 1,28% | 2,46% | 2,35% |
Announcement Date | 3/24/22 | 3/16/23 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
BUY
Number of Analysts
9
Last Close Price
2.412GBP
Average target price
2.507GBP
Spread / Average Target
+3.92%
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.54% | 2 412 M $ | |
+4.86% | 111 B $ | |
+41.99% | 91 411 M $ | |
+13.86% | 55 559 M $ | |
+40.87% | 51 403 M $ | |
+4.39% | 36 546 M $ | |
+12.45% | 35 433 M $ | |
+71.75% | 28 117 M $ | |
-7.90% | 22 045 M $ | |
-8.43% | 22 318 M $ |
- Stock
- Equities
- Stock Bridgepoint Group plc - London Stock Exchange
- Financials Bridgepoint Group plc